Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMSA Chelation for Autism
NCT00376194Phase 2Withdrawn
- Sponsor
- National Institute of Mental Health
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of succimer in Autism Spectrum Disorder (ASD), sponsored by National Institute of Mental Health. Planned start Sep 2006; status: withdrawn.
02
Drugs
succimer
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00376194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376194.